The U.S. government on Friday proposed 2026 reimbursement rates for Medicare Advantage plans run by private insurers that ...
Any lasting fiscal reforms must moderate the growth of the largest mandatory spending programs: Social Security, Medicare and ...
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
Medicare bills are increasing for millions of Americans despite a $2,000 prescription drug cap beginning in 2025, as premiums ...
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...
There’s a major change in 2025 to Medicare’s prescription drug coverage. This year, there’s a new $2,000 cap on annual out-of ...
MA plans are substantially overpaid compared to traditional Medicare. Much of these overpayments benefit the MA plans rather ...
Politico has acquired an early list from Republican lawmakers that shows the programs they're considering slashing from the ...
The Biden administration’s final regulation affecting the Medicare Advantage industry would come with a much lighter touch ...